TY  - JOUR
AU  - Morgensztern, Daniel
AU  - Dols, Manuel Cobo
AU  - Ponce Aix, Santiago
AU  - Postmus, Pieter E.
AU  - Bennouna, Jaafar
AU  - Fischer, Jürgen R.
AU  - Juan-Vidal, Oscar
AU  - Stewart, David J.
AU  - Ardizzoni, Andrea
AU  - Bhore, Rafia
AU  - Wolfsteiner, Marianne
AU  - Reck, Martin
AU  - Talbot, Denis
AU  - Govindan, Ramaswamy
AU  - Ong, Teng Jin
PY  - 2021
DO  - 10.3389/fonc.2020.569715
UR  - http://hdl.handle.net/10668/4015
T2  - Frontiers in Oncology
AB  - Background: The standard therapy for advanced stage non-small cell lung cancer (NSCLC) with no actionable gene alterations is a platinum-based chemotherapy doublet and immune checkpoint blocker (ICB), either concurrently or sequentially, followed by...
LA  - en
PB  - Frontiers Research Foundation
KW  - Advanced stage non-small cell lung cancer
KW  - Durvalumab
KW  - Immune checkpoint blocker plus chemotherapy
KW  - nab-paclitaxel
KW  - Second-line therapy
KW  - Carcinoma de pulmón de células no pequeñas
KW  - Puntos de control inmunológico
KW  - Quimioterapia
KW  - Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans
KW  - Medical Subject Headings::Check Tags::Female
KW  - Medical Subject Headings::Check Tags::Female
KW  - Medical Subject Headings::Persons::Persons::Age Groups::Adult::Middle Aged
KW  - Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung
KW  - Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms
KW  - Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Asthenia
KW  - Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Signs and Symptoms, Digestive::Diarrhea
KW  - Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Variation::Mutation
KW  - Medical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Transferases::Phosphotransferases::Phosphotransferases (Alcohol Group Acceptor)::Protein Kinases::Protein-Tyrosine Kinases::Receptor Protein-Tyrosine Kinases
TI  - nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)
TY  - research article
ER  -